Document Detail


Preliminary Phytochemical Screening and In Vitro Anti-Helicobacter pylori Activity of Acetone and Aqueous Extracts of the Stem Bark of Sclerocarya birrea (Anacardiaceae).
MedLine Citation:
PMID:  21722823     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Helicobacter pylori antibiotic resistance and other problems associated with combination therapy have generated a considerable interest in the search for alternative therapeutic agents. In order to identify novel sources of such agents, the antimicrobial activity of five solvent extracts of the stem bark of Sclerocarya birrea was investigated against 30 clinical strains of H. pylori and a reference strain NCTC 11638 using standard microbiological techniques. Metronidazole and amoxicillin were included in these experiments as positive control antibiotics. The active phytocomponents were detected by TLC and indirect bioautography. All the extracts exhibited anti-H. pylori activity with zone diameters of inhibition between 0 and 21 mm. The acetone and aqueous extracts showed potent anti-H. pylori activity with minimum inhibitory concentration (MIC(90)) values ranging from 0.06-2.50 mg/mL, whereas those for the control antibiotics ranged from 0.001-5.0 mg/mL. The acetone extract was highly bactericidal at 1.2 mg/mL with complete elimination of the organisms within 18 h. The activity of both acetone and aqueous extracts was better than metronidazole (p <0.05). Most of the active phytocomponents were located in the acetone extract; R(f) ≤0.62 with >90% inhibition. These results demonstrate that the acetone and aqueous extracts of S. birrea may contain compounds with therapeutic activity; therefore, they may represent potential sources of new anti-H. pylori regimen.
Authors:
Collise Njume; Anthony J Afolayan; Roland N Ndip
Related Documents :
10882903 - Characterisation of bangladeshi leishmania isolated from kala-azar patients by isoenzym...
25414513 - Complete genome sequence of lactococcus lactis strain ai06, an endophyte of the amazoni...
18086853 - In vitro capability of faropenem to select for resistant mutants of streptococcus pneum...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Archives of medical research     Volume:  42     ISSN:  1873-5487     ISO Abbreviation:  Arch. Med. Res.     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-07-04     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9312706     Medline TA:  Arch Med Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  252-7     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 IMSS. Published by Elsevier Inc. All rights reserved.
Affiliation:
School of Biological and Environmental Sciences, Faculty of Science and Agriculture, University of Fort Hare, Alice, South Africa.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Contribution of Serum Leptin to Metabolic Syndrome in Obese and Nonobese Subjects.
Next Document:  Does the expression of versican isoforms contribute to the pathogenesis of neurodegenerative disease...